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Abstract
Purpose:
The minimally invasive treatment of ureteropelvic junction obstruction has evolved during
the last decade from endoscopic to laparoscopic and robotic. We review our 10-year
experience with ureteropelvic junction obstruction, and report on our experience and
followup.
Materials and Methods:
We reviewed all patients treated during the last 10 years. There were 294 procedures
performed with complete records on 273 patients including 128 retrograde
endopyelotomies, 116 laparoscopic pyeloplasties and 29 robotic pyeloplasties. Technique
for each procedure is reviewed. Statistical analysis was performed on all results. Variables
evaluated were gender, age (younger than 41 vs 41 years or older), side (right or left),
presence of crossing vessels, presence of a high insertion, primary or secondary procedure
and whether prior endopyelotomy or pyeloplasty had been performed.
Results:
Mean followup for endopyelotomy, laparoscopic pyeloplasty and robotic pyeloplasty was
20, 20 and 19 months, respectively, with success rates of 60.2%, 88.8% and 100%,
respectively. On univariable analysis only the presence of crossing vessels or a high
insertion was significant for laparoscopic pyeloplasty. On multivariable analysis age was
significant for endopyelotomy and the presence of crossing vessels was significant for
pyeloplasty. On Kaplan-Meier analysis failures were noted to occur after 5 years in both
groups.
Conclusions:
Laparoscopic pyeloplasty and robotic pyeloplasty are superior minimally invasive

treatments for ureteropelvic junction obstruction. However, endopyelotomy can be used for
select patients. Because of late failures patients who undergo either of these procedures
should receive long-term followup.
Key Words: ureteral obstruction, laparoscopy, robotics

In the last decade open pyeloplasty has largely been replaced by minimally invasive
approaches for the treatment of ureteropelvic junction obstruction in adults. In the 1980s
antegrade endopyelotomy by cold knife performed through a nephrostomy tract was first
1
reported. This technique offered the advantage of being able to treat considerable renal
calculus burdens during the same procedure. However, it requires the establishment of a
nephrostomy tract before the endopyelotomy can be performed as well as longer hospital
stays. Ureteroscopic endopyelotomy soon followed, initially described as pyelolysis using
2
the rigid ureteroscope. It was difficult to reach the ureteropelvic junction with a rigid
ureteroscope and the availability of flexible instruments prompted the wider acceptance of
3
flexible ureteroscopic endopyelotomy.
Since the first published reports in 1993 laparoscopic pyeloplasty has proven to be safe
and effective with outcomes comparable to the open procedure and superior to
4–6
endopyelotomy. One drawback has been the relatively steep learning curve for this
procedure. In particular, intra-corporeal suturing with laparoscopic instruments can be
technically demanding.
The da Vinci® Surgical System has enabled these laparoscopic techniques to be
performed with greater ease and, in the process, has expanded the use of laparoscopy in
urology. The known advantages of the robotic system to the surgeon allow for more
efficient intracorporeal suturing. This has led to shorter operative times with similar
7,8
success rates compared to the straight laparoscopic approach. We present our experience
with the minimally invasive treatment and long-term followup of UPJO.
MATERIALS AND METHODS
After institutional review board approval charts of all patients treated for UPJO at our
institution from 1995 to 2006 were retrospectively reviewed. A total of 294 patients
underwent minimally invasive treatment. The initial diagnosis of UPJO was based on
subjective criteria such as flank pain and pyelonephritis or incidental findings from
radiological evaluation of unrelated medical conditions. Radiological verification was

obtained by excretory urography or CT urography. In addition, all patients had preoperative
diuretic renogram to establish baseline renal function including split renal function and the
degree of obstruction. Evaluation for crossing vessels was performed by CT angiogram or
endoluminal ultrasound. For patients undergoing pyeloplasty indwelling stents were
removed 2 to 3 weeks before the procedure. It is our belief that indwelling stents increase
edema and UPJ wall thickening, making for a more difficult dissection and reconstruction
of the UPJ.
9

Our technique of endopyelotomy has been described previously. We begin with a
retrograde pyelogram which demonstrates the length of the UPJ narrowing and identifies
any additional ureteral strictures. This is followed by endoluminal ultrasound using a 6Fr
probe. We can identify the presence of crossing vessels noting their size and location as
10,11
well as a septum which indicates a high ureteral insertion into the UPJ.
After placement
of a safety wire a flexible ureteroscope is introduced and the UPJ is visualized. The
information collected from these imaging studies determines the site and length of the
incision. Endopyelotomies early in our series were performed using a small diameter
electrode, but this has largely been replaced by the 200 micron holmium laser fiber with
preferred energy and frequency settings of 1.2 to 1.5 Joules per pulse and 10 to 15 Hertz,
respectively. The incision is made through the entire thickness of the ureter. Finally a
balloon catheter is deployed to calibrate the incision and open the adventitia. A ureteral
stent is then placed which is removed approximately 6 to 8 weeks after surgery.

Positioning and exposure for LP and RP are essentially the same. The patient is
positioned in a modified 45-degree flank position. Cystoscopy is performed to pass a
guidewire into the proximal ureter for later stent placement. A standard 4 trocar
arrangement is used which includes a 12 mm periumbilical trocar for the laparoscope
anda5mm assistant trocar. LP uses a pair of 5 mm working trocars while RP replaces these
with a pair of 8 mm da Vinci trocars. Dissection begins with medial reflection of the colon
and is followed by isolation of the ureter at a location inferior to the lower pole of the
kidney. The ureter is mobilized, and traced up to the UPJ and renal pelvis. If present,
crossing vessels are identified and preserved. Once the UPJ is fully dissected
dismemberment is performed and the affected segment is resected. Crossing vessels are
repositioned posterior to the anastomosis and after ureteral spatulation the anastomosis is
completed using 4-zero polyglactin sutures over an indwelling ureteral stent. The stent
remains in place for 6 weeks.

Currently for all patients a diuretic renogram is performed at 3 and 6 months, and 1 year
postoperatively. Additionally, if the initial renogram is normal an ultrasound is
occasionally used afterward if the patient remains asymptomatic. A renal ultrasound or
diuretic renogram is also obtained annually thereafter. Successful repair is defined as
resolution of preoperative symptoms and improvement or stability of radiographic
parameters. When we evaluate our patients using t½ criteria success is defined with t½ less
than 10 minutes (strict success) or 10 to 20 minutes (relative success). When the renogram
demonstrates delayed drainage (more than 20 minutes) but shows relative improvement in

the t½ compared to preoperative values, as long as the patient remains asymptomatic and
the split function improves or stays stable, then the repair is also considered patent.
Alternatively if the t½ demonstrates relative success (10 to 20 minutes) and the patient has
a relapse of symptoms and a decline in function by diuretic renogram, the repair is
considered a failure. Cox regression hazard ratios and Kaplan-Meier failure-free estimates
were determined for the endopyelotomy and LP populations.

RESULTS
We reviewed 145 retrograde endopyelotomies, 120 LPs and 29 robotic assisted
laparoscopic pyeloplasties (RPs) with followup available on 128 (88.3%), 116 (96.7%) and
29 (100%), respectively. Patient characteristics of each group with followup are presented
in table 1. The number of each procedure performed by year is presented in figure 1.
Median followup (range) for the endopyelotomy, LP and RP groups was 20 (1 to 165), 20
(1 to 87) and 19 (13 to 25) months, respectively. The overall success rate for the
endopyelotomy group was 60.2% and for the LP group was 88.8%. There have yet to be
failures in the RP group. Univariable and multivariable analysis is presented in table 2. On
univariable analysis there was no difference in success for the endopyelotomy group when
examining sex, presence of crossing vessels or high insertion, primary vs secondary repair,
side or age. In the LP group the only statistically significant differences on univariable
analysis were for the presence of crossing vessels and high insertion (p = 0.028 for each).
On multivariable analysis undergoing LP was statistically significant (p <0.001) as was age
41 years or older (p = 0.003). In the endopyelotomy group age was the only significant
variable (p = 0.014) while the presence of crossing vessels was the only significant variable
in the LP group (p = 0.028). Kaplan-Meier 1, 3 and 7-year failure-free estimates for
endopyelotomy were 82%, 62% and 50%, and for LP were 93%, 86% and 76%,
respectively (p <0.001) (fig. 2). In the RP group 31% of the repairs were for secondary
UPJO and 20 patients overall were found to have crossing vessels. Because of shorter
followup these patients were not included in the statistical analysis.

DISCUSSION
We found the success rate for LP to be significantly greater than for endopyelotomy.
However, while a majority of treatment failures occurred within the first 2 years for both
groups there were still failures as followup continued. As a result success rates were lower
than has generally been described, in part because many studies have short 1 to 2-year
4,5,12
followup.
Our findings are notably similar to those of Dimarco et al, who found
estimated 3, 5 and 10-year recurrence-free survival rates for endopyelotomy to be 63%,
55% and 41%, respectively, compared to 85%, 80% and 75% for pyeloplasty (p <0.001)
13
(fig. 3).

The implications of these findings are far-reaching. For endopyelotomy and pyeloplasty
we contend that patients should have long-term followup, which is contradictory to what
14,15
has been recommended in the past.
In addition, we have changed our followup for
endopyelotomy and pyeloplasty to be more consistent with our findings. Although we still
see patients every 3 to 6 months in the year after treatment with a functional study, we now
see them annually thereafter with renal ultrasound and diuretic renogram, if needed, to
evaluate for new hydronephrosis, cortical loss or return of symptoms. When evaluating t½
we consider relative improvement in addition to strict (less than 10 minutes) and relative
(10 to 20 minutes) success. There were 2 patients in the endopyelotomy group and 1 in the
pyeloplasty group who had a t½ that was persistently more than 20 minutes after repair. In
all 3 patients this represented an improvement compared to preoperative values and the
patients remained asymptomatic with stable differential function. These repairs were
regarded as successful. Alternatively 1 patient in each group had a t½ that was 10 to 20
minutes after repair but had a postoperative return of symptoms and a decline in renal
function. Although the t½ showed relative success, both of these cases were considered
failures.

Our identification of long-term failures is especially relevant for the RP group, in which
no failures have been recognized with relatively short followup. All of these patients have
demonstrated strict or relative success by postoperative t½ values. However, based on the
previously mentioned failure-free estimates it would not be unreasonable to expect failures
as surveillance continues.

On multivariable analysis the presence of crossing vessels led to a statistically significant
improvement in success in the LP group. Because of prior experience we did not treat these
10
patients with endopyelotomy, thus selecting out those at high risk for failure. An
explanation for the statistical significance in LP could be that crossing vessels provide a
definitive target for repair. This would allow for pinpoint identification and reconstruction
of the affected area leading to improved success rates. We routinely transpose any lower
pole crossing vessels lateral to our repair, although the necessity of this has recently been
16
called into question. Regardless of this controversy, like others we contend that crossing
vessels, when present, represent a clear etiology of obstruction that needs to be addressed
17,18
for a repair to be successful.
In addition, we found that age younger than 41 years was
significant for success in endopyelotomy. However, this was not the case for the LP group.
When considering treatment options with respect to age we choose LP for younger patients
because of better long-term success. Other variables that we did not evaluate which likely
would have also proved significant and have also been recognized by other groups are
12,19,20
severe hydronephrosis and preoperative renal function.

Other single institution comparisons of endopyelotomy and pyeloplasty for UPJO have
12,13,19
been made.
However, in 2 of these reports antegrade endopyelotomy was the
12,13
endoscopic method used.
In the series by Rassweiler et al laser endopyelotomy was

19

used with a success rate of 78.3%. However, their Kaplan-Meier estimation of success
included a time course that extended out to half of what we reported. Arguably with longer
followup they would have realized more failures and they actually concluded at the end of
their study that, even with careful patient selection, endopyelotomy was inferior to
pyeloplasty in direct comparison. Our series, to our knowledge the largest reported with
long followup, confirms this conclusion. This can be inferred from our practice patterns
during the last decade (fig. 1). Currently the only patients for whom we are recommending
endopyelotomy primarily are those who have an absence of crossing vessels and severe
hydronephrosis (detected intraoperatively by endoluminal ultrasound and retrograde
pyelogram, respectively), and who are otherwise poor surgical candidates or refuse a more
invasive procedure. Still, with low morbidity and high success rates pyeloplasty
(laparoscopic or robotic) is the definitive minimally invasive procedure for UPJO, and any
patient younger than 40 years with salvageable renal function, regardless of UPJ pathology,
is treated with either of these operations at our institution. Other putative benefits of LP/RP
include the ability to treat patients with UPJO with aberrant anatomy, different degrees of
hydronephrosis or concomitant calculi. Furthermore, with the advent of robotic technology,
which may not add anything to LP in experienced hands but will help to disseminate it
among less skilled urologists, the procedure will become more widespread. At our
institution the decision between LP and RP is surgeon dependent, and is not influenced by
individual patient or pathological considerations.

CONCLUSIONS
While laparoscopic pyeloplasty continues to have significantly improved outcomes
compared to endopyelotomy, anticipated rates of success appear to be less than previously
reported. It is clear that remote failures do occur in both groups and, therefore, these
patients should be continually followed. However, with long-term followup pyeloplasty
remains superior. The presence of crossing vessels is a positive predictor for patients who
undergo pyeloplasty and patients with this UPJ pathology should be treated with this
procedure. Finally robotic pyeloplasty parallels the success of LP and will likely make this
procedure more common, thus further minimizing the role of endopyelotomy.
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ABBREVIATIONS AND ACRONYMS
CT = computerized tomography
LP = laparoscopic pyeloplasty
RP = robotic pyeloplasty
t½ = half-time

UPJ = ureteropelvic junction
UPJO = ureteropelvic junction obstruction
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Figures and Tables
FIG. 1.
Practice patterns for treatment of UPJO during last decade. Cases from 2007 not included
in statistical analysis.

FIG. 2.
Kaplan-Meier estimates of failure-free probability for endopyelotomy and laparoscopic
pyeloplasty.

FIG. 3.
Comparative success rates of endopyelotomy and laparoscopic pyeloplasty. Solid line
13
indicates findings of Dimarco et al. Broken line indicates findings of current study.

TABLE 1. Patient characteristics
No. (%)
Total pts
Sex:
Male
Female
Crossing vessels:*
Yes
No
High insertion:†
Yes
No
Repair:
Primary
Secondary
Prior endopyelotomy:
Yes
No
Prior pyeloplasty:
Yes
No
Side:
Rt
Lt
Age:
Younger than 41
41 or Older
Success:
Yes
No
* LP in 114 patients.
† LP in 59 patients.

Endopyelotomy
128

LP
116

RP
29

Totals
273

46 (35.9)
82 (64.1)

50 (44.2)
66 (58.4)

11 (37.9)
18 (62.1)

107 (39.1)
166 (60.9)

52 (40.6)
76 (59.4)

80 (70.2)
34 (29.8)

20 (69.0)
9 (31.0)

152 (56.1)
119 (45.9)

78 (60.9)
50 (39.1)

18 (30.5)
41 (69.5)

Not available
Not available

96 (51.3)
91 (48.7)

91 (71.1)
37 (28.9)

84 (72.4)
32 (27.6)

20 (69.0)
9 (31.0)

195 (71.4)
78 (28.6)

27 (21.1)
101 (78.9)

25 (21.6)
91 (78.4)

9 (31.0)
20 (69.0)

61 (22.3)
212 (77.7)

13 (10.2)
115 (89.8)

3 (2.6)
113 (97.4)

0 (0.0)
29 (100.0)

16 (5.9)
157 (94.1)

69 (53.9)
59 (46.1)

62 (53.4)
54 (46.6)

18 (62.1)
11 (37.9)

149 (54.6)
124 (45.4)

73 (57.0)
55 (43.0)

50 (43.1)
66 (56.9)

15 (51.7)
14 (48.3)

138 (50.5)
135 (49.5)

77 (60.2)
51 (39.8)

103 (88.8)
13 (11.2)

29 (100)
0 (0.0)

209 (76.6)
64 (23.4)

TABLE 2. Cox regression hazard ratios

Univariable analysis:
Endopyelotomy vs laparoscopy
Sex (male vs female)
Crossing vessels (yes vs no)
High insertion (yes vs no)
Primary vs secondary repair
Prior endopyelotomy (yes vs no)
Prior pyeloplasty (yes vs no)
Side (rt vs lt)
Age (younger than 41 vs 41 or older)
Multivariable analysis:
Endopyelotomy vs laparoscopy
Age (younger than 41 vs 41 or older)
Crossing vessels (yes vs no)

All Data
HR (95% CI)
p Value

Endopyelotomy Only
HR (95% CI)
p Value

LP Only
HR (95% CI)

p Value

2.85 (1.54, 5.28)
0.70 (0.42, 1.18)
0.75 (0.46, 1.23)
0.90 (0.54, 1.52)
1.33 (0.77, 2.29)
0.96 (0.54, 1.72)
0.77 (0.31, 1.93)
1.18 (0.72, 1.93)
1.90 (1.15, 3.15)

0.001
0.178
0.253
0.702
0.315
0.895
0.577
0.519
0.012

0.68 (0.38, 1.24)
1.32 (0.76, 2.28)
0.51 (0.29, 0.88)
1.36 (0.73, 2.53)
0.99 (0.51, 1.94)
0.63 (0.25, 1.59)
0.97 (0.56, 1.69)
2.01 (1.15, 3.51)

0.211
0.330
0.017
0.326
0.988
0.329
0.909
0.014

1.01 (0.34, 3.00)
0.27 (0.08, 0.87)
6.31 (1.22, 32.54)
1.17 (0.36, 3.81)
1.13 (0.34, 3.72)
Not estimated
2.29 (0.70, 7.44)
2.84 (0.78, 10.34)

0.990
0.028
0.028
0.800
0.843
0.994
0.169
0.112

3.16 (1.70, 5.86)
2.15 (1.30, 3.57)

<0.001
0.003

2.01 (1.15, 3.51)

0.014
0.27 (0.08, 0.87)

0.028

